Message the manager to join our researchers' chat
Ask a question manager online
UK RU EN
Мова
UK RU EN
Валюта
Shopping Cart
Catalog /Research Chemicals /9-Me-BC powder (9-methyl-beta-carboline)
Rare
In Stock
9-Me-BC powder (9-methyl-beta-carboline)

9-Me-BC powder (9-methyl-beta-carboline)

9-Me-BC · 9 Me BC · 9-MBC · 9-methyl-β-carboline

Purity ≥98% HPLC · PASS
Specification
IUPAC5-Methyl-5H-pyrido[3,4-b]indole
CAS2521-07-5
FormulaC₁₂H₁₀N₂
Mol. weight182.23 г/моль
Purity≥98% · HPLC
Formpowder
Appearancewhite
PubChemCID 164979
Place an order
$40.00
1
● In stock · we ship today before 17:00
Purity ≥98%, verified by HPLC
CoA for every lot
Nova Poshta, 1–2 days in Ukraine
Payment by card or USDT
Compound description

What is 9-Me-BC

9-Methyl-beta-carboline (9-Me-BC) is a synthetic heterocyclic amine of the β-carboline family. Methylation at the N-9 position produces a unique profile of dopaminergic neurostimulation, neuroprotection, and neuroregenerative activity.

Dopamine Synthesis Stimulation The primary mechanism is upregulation of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. In primary mesencephalic cultures, 9-Me-BC doubles the number of TH⁺ neurons. The effect is independent of D2/D3 receptors (sulpiride blockade does not abolish the response) and is mediated via the PI3K cascade. A 2012 study (J. Neurochem.) in rats demonstrated significant hippocampal dopamine elevation alongside dendritic and synaptic proliferation, accompanied by improved cognitive performance in behavioral tests.

MAO Inhibition Reversible inhibitor of MAO-A (IC₅₀ = 1 μM) and MAO-B (IC₅₀ = 15.5 μM). Reduced dopamine degradation in the synaptic cleft synergizes with TH upregulation: the compound simultaneously increases synthesis and extends neurotransmitter dwell time.

Neurogenesis and Neurite Outgrowth Stimulates differentiation of progenitors into mature dopaminergic neurons, increases dendritic arborization and synaptic density. Via astrocytes, upregulates BDNF, GDNF (Artn), TGF-β2, and NCAM1. Restores dopaminergic neurons after chronic rotenone treatment in vitro; reduces α-synuclein levels in parkinsonism models.

Anti-inflammatory Activity Suppresses microglial proliferation and reduces chemotactic cytokine levels in the CNS.

Photosensitization The compound may induce UV photosensitivity. Store in dark opaque containers, protect from direct light exposure.

For research use only. This product is not a medicine, food supplement or cosmetic. Not intended for human or animal use. Sold to persons aged 18+.